N/A N=6 Randomized Single-blind Treatment

Laser Resurfacing Versus Dermabrasion for Scar Revision

Cicatrix · Dermabrasion · Coagulation, Laser

Bottom Line

View on ClinicalTrials.gov: NCT01176448 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2013

Primary outcome: Primary: Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing — 1.33; 3.00; 0; 0 units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Fractionated laser (Device); Dermabrasion (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Minnesota
Primary completion: Aug 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing	1.33; 3.00; 0; 0; 1.08; 2.0	—
SECONDARY Visual Analog Scale for Assessing Scar Improvement.	1.53; 1.49	.77

Summary

Dermabrasion has been the historical standard used for resurfacing scars on the skin. Recently, fractionated laser therapy has been FDA approved for scar resurfacing. This study intends to compare dermabrasion versus fractionated laser therapy for scar resurfacing.

Eligibility Criteria

Inclusion Criteria

Post-surgical or post traumatic scar on face or scalp.
Age 18 or older
Able to read and comprehend English
Willing to follow treatment schedule and post treatment care requirements
Signed the informed consent form
Fitzpatrick skin type I-III

Exclusion Criteria

known photosensitivity
Taken any medications known to induce photosensitivity in previous three months
Taken Accutane within past 12 months
Pregnant or nursing
Currently on topical or oral antibiotics
Immunocompromised status
Skin type IV or greater

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01176448). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.